Status:
UNKNOWN
Follow-up Study of the Alzheimer's Disease Anti-Inflammatory Prevention Trial
Lead Sponsor:
Seattle Institute for Biomedical and Clinical Research
Collaborating Sponsors:
VA Puget Sound Health Care System
National Institute on Aging (NIA)
Conditions:
Alzheimer Disease
Dementia
Eligibility:
All Genders
75+ years
Brief Summary
The Alzheimer's Disease Anti-inflammatory Prevention Trial - Follow-up Study (ADAPT-FS) will continue observations of the declared primary outcomes of the Alzheimer's Disease Anti-inflammatory Prevent...
Detailed Description
ADAPT was a multicenter, randomized, placebo-controlled trial designed to test the safety and efficacy of naproxen and celecoxib for the primary prevention of Alzheimer's Disease (AD) dementia and for...
Eligibility Criteria
Inclusion
- Subjects must have been enrolled previously in the Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT).
Exclusion
- Individuals not previously enrolled in the ADAPT trial.
Key Trial Info
Start Date :
August 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2012
Estimated Enrollment :
1650 Patients enrolled
Trial Details
Trial ID
NCT01417130
Start Date
August 1 2009
End Date
August 1 2012
Last Update
January 9 2012
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Banner Sun Health Research Institute
Sun City, Arizona, United States, 85351
2
The Roskamp Institute
Sarasota, Florida, United States, 34243
3
The Johns Hopkins University
Baltimore, Maryland, United States, 21205
4
Boston University School of Medicine
Boston, Massachusetts, United States, 02118